Stocks
Heron Therapeutics (HRTX) Debt/EBITDA US GAAP (year values) |
||||||||
| 2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | |||
| Debt/EBITDA | 1.84 | 0.83 | -0.01 | -0.41 | -0.96 | -4.83 | ||
| Changes by years, y/y, % | +4% | -55% | -101% | +4 521% | +133% | |||
Heron Therapeutics. Debt/EBITDA
Heron Therapeutics. Debt/EBITDA, changes, %
Heron Therapeutics (HRTX) Debt/EBITDA US GAAP (quarter values) |
||||||||
| 2023Q3 | 2023Q4 | 2024Q1 | 2024Q2 | 2024Q3 | LTM ? | |||
| Debt/EBITDA | -0.87 | -0.94 | -1.39 | -2.69 | -4.83 | -4.83 | ||
| Changes by years, y/y, % | +399% | +123% | +105% | +196% | +456% | |||
| Changes by quarters, q/q, % | -4% | +8% | +48% | +93% | +80% | |||
